Skip to main content

Table 3 Association between CLT and clinicopathological characteristics in patients ≥ 55 years

From: Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients

Charateristics Total non-CLT(%) CLT-coexisted(%) OR(95%CI) P value
Number of patients 120 81 (67.5) 39 (32.5)   
Sex
Female 101 65 (80.2) 36 (92.3) 3.0 (0.8–10.8) 0.09
Male 19 16 (19.8) 3 (7.7)   
Small lesion (Dmax ≤ 1 cm) 61 40 (49.4) 21 (53.8) 0.8 (0.4–1.8) 0.29
#Mean rank of lesion size   60.97 59.53   0.817
0 < size ≤ 1 cm   40 (49.4) 21 (53.8)  
1 cm < size ≤ 2 cm   18 (22.2) 6 (15.4)  
2 cm < size ≤ 4 cm   20 (24.7) 11 (28.2)  
4 cm < size   3 (3.7) 1 (2.6)  
Extrathyroidal extension 27 20 (24.7) 7 (17.9) 0.7 (0.3–1.7) 0.41
CLNM 24 17 (21.0) 7 (17.9) 0.8 (0.3–2.2) 0.7
LLNM 1 1 (1.2) 0 (0.9–1.0) 0.49
CLNM of small lesions 4 3 (6.3) 1 (4.5) 0.7 (0.1–7.3) 0.63
TNM stage
I 108 72 (88.9) 36 (92.3) 0.7 (0.2–2.6) 0.56
II-IV 12 9 (11.1) 3 (7.7)   
Multifocality 42 31 (38.3) 11 (28.9) 0.7 (0.3–1.5) 0.32
  1. CLNM central lymph node metastasis, LLNM lateral lymph node metastasis, OR odds ratio, #Mann–Whitney U test used